706 results on '"Sayer, G."'
Search Results
2. (849) - The Ability of CPET to Predict TR Dynamics Post LVAD
3. (836) - Mechanism and Clinical Impact of Late Tricuspid Regurgitation in Patients with Heartmate 3
4. (824) - Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls
5. (821) - Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients
6. (588) - Surgical Interventions for Accumulation of Biodebris Causing Outflow Graft Obstruction and Thrombosis Following HeartMate 3
7. (568) - Outcomes Comparison of Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock with Acute Decompensated Heart Failure versus Acute Myocardial Infarction
8. (564) - Relation Between Indexed Surgery and Outcomes in Postcardiotomy Venoarterial Extracorporeal Life Support
9. (540) - Increased Incidence of Stroke After Heart Transplant in the New Allocation System Era
10. (488) - Microcirculatory Dysfunction in Cardiogenic Shock
11. (487) - Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock
12. (458) - History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)
13. (446) - Cardiometabolic Outcomes Associated with the use of Semaglutide After Heart Transplantation
14. (436) - Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results
15. (417) - Clinical Implications of Borderline Rejection Assessed by Molecular Microscope
16. (415) - Microvascular Responses to Donor Specific HLA Antibodies in Heart Transplantation. Sidestream Dark Field Imaging Results
17. (414) - Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls
18. (1411) - Sodium Glucose Co-Transporter 2 Inhibitor Use in HeartMate 3 Patients
19. (1293) - Omental Wrapping for Refractory Driveline Infection After HeartMate 3 Implantation
20. (1222) - Regional Variation and One-Year Outcomes of Heart Transplantation from Donation After Circulatory Death Donors in the United States
21. (1170) - Should Living Alone be an Absolute Contraindication to HeartMate 3 Implantation: A Single Center Experience
22. (1154) - Heart Transplantation in a Patient with Active Thyroid Cancer
23. (1137) - Implantable Pulmonary Artery Pressure Sensor Monitoring in a Heart Transplant Recipient
24. (1117) - Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
25. (1094) - Hypertrophic Cardiomyopathy Patients Have More Adverse Hemodynamic Profiles on Pre-Transplant Cardiopulmonary Exercise Testing
26. (1085) - LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope
27. (1080) - Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope
28. (1081) - Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation
29. (783) - Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)
30. (778) - Correlation Between the Subtype of Anti-HLA Donor Specific Antibodies and Rejection Assessed by Molecular Microscope
31. (762) - Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed
32. (763) - Decreased Cardiac Mass in Cancer Survivors with Anthracycline Induced Cardiotoxicity Undergoing Heart Transplantation
33. (741) - Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?
34. (736) - Molecular Microscope (MMDx) After COVID-19 Vaccination in Heart Transplant Recipients
35. (737) - Association of Sarcopenia, Obesity and Sarcopenic Obesity with Inflammation in Advanced Heart Failure
36. (390) - CAV Grading by PET Provides Improved Risk Stratification Compared to CA
37. (391) - CAV by PET/MBF Has Robust Negative Predictive Value for Development of Moderate to Severe CAV
38. (389) - CAV Trajectories Among Patients with No or Mild CAV at 10 Years Post-Transplant
39. (372) - Molecular Microscope (MMDx) Results in the Sensitized Heart Transplant Recipient
40. (371) - Heart Failure Hospitalizations are Associated with Changes in Gut and Oral Microbiome
41. (348) - Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients
42. (331) - Cystatin C- Based Estimated Glomerular Filtration Rate: A Predictive Metric for Long-Term Heartmate 3 Survival
43. (284) - Serial Assessment of MBFR Identifies Heart Transplant Recipients with an Increased Risk of Mortality
44. (264) - Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock
45. (260) - Cystatin C-Based Estimated Glomerular Filtration Rate is Independently Associated with Long-Term Mortality in HeartMate3 Patients
46. (247) - Outcomes of Transport on Venoarterial Extracorporeal Life Support in Cardiogenic Shock Patients
47. (202) - Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients
48. (185) - Epicardial and Microvascular CAV are Associated with Restrictive Physiology After Heart Transplantation
49. (183) - Myocardial Blood Flow Assessment with PET Improves Risk Stratification Among HT Recipients with CAV1
50. (29) - Social Work Evaluation Domains Related to Caregiver Support and Mental Health are Strong Predictors of Risk of Readmission or Driveline Infection After HeartMate 3 (HM3)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.